(March 1, 2019) OCRA mourns the loss of our beloved board member and friend, Lori Newcomb. We are profoundly grateful for her vision and dedication in creating Newk’s Cares along with her loving husband, Chris, to support ovarian cancer research through their family business, Newk’s Eatery. Her unwavering and selfless commitment to help other women and to find a cure for this terrible disease is a testament to her incredible character. And her feisty, funny and infectious personality that shined so brightly will be sorely missed. Lori’s dedication and work to end ovarian cancer will live on through her legacy and will one day ensure that no other woman has to endure this terrible disease. Sending our love to Chris, Madison, Blair and Hayes.
Related Topics
OCRA Sponsors NCCN 2025 Guidelines for Cervical, Ovarian, and Uterine Cancer Patients
This article was updated in October 2025 to reflect NCCN’s release of the 2025 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2025 Patient Guidelines for Cervical, Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful guides for anyone newly diagnosed to help … Continued
OCRA’s Survivors Teaching Students Program Spotlighted by Fort Worth Star-Telegram
In a recent article for the Fort Worth Star-Telegram, Jeff Guttenfelder spoke with journalist Ciara McCarthy about losing his late wife, Ni, to ovarian cancer, and how he is channeling his grief into action through participation in OCRA’s Survivors Teaching Students program. Read the article “Fort Worth man’s wife died of ovarian cancer” in the … Continued
KVIA-TV ABC-7 Features OCRA-Funded Research Developing Nanotechnology for Ovarian Cancer Detection
KVIA-TV ABC-7 News El Paso recently spotlighted the groundbreaking work of OCRA-funded researcher Daniel Heller, PhD of Memorial Sloan Kettering Cancer Center, whose research lab is working to develop a liquid biopsy that uses nanotechnology and artificial intelligence (AI) to detect ovarian cancer earlier. We’re developing a liquid biopsy that uses nano sensors and AI … Continued